13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q3 2016. See the latest, Q2 2026 →
Reported value
$302.53B
+3.4% on the quarter before
Positions
413
25 new · 31 sold out
Top 10
24.6%
of the value
Est. gain
+$11.83B
on stocks held all quarter
Est. return
+4.3%
on those stocks since Q2 2016
Positions as of Sep 30, 2016, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 42% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2016. Striped tiles are options.
Largest buys
Since Q2 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Exxon Mobil Corp~$954.4MAdded · 0.5% → 0.8%+10,934,457 shares
- Abbvie Inc~$539.4MAdded · 3.2% → 3.4%+8,556,414 shares
- IBM~$535.4MAdded · 0.4% → 0.6%+3,370,705 shares
- Transcanada Corp~$497.5MNew · 0.0% → 0.2%+10,475,000 shares
- Southern Company~$428.6MAdded · 0.1% → 0.2%+8,354,000 shares
- Prudential Financial Inc~$425.5MNew · 0.0% → 0.1%+5,210,932 shares
- Reynolds American Inc~$425.5MAdded · 0.4% → 0.5%+9,023,817 shares
- Apple~$419.2MAdded · 0.5% → 0.7%+3,708,199 shares
- Mckesson Corp~$411.1MAdded · 0.6% → 0.6%+2,465,070 shares
- Johnson Controls International Plc~$405.4MNew · 0.0% → 0.1%+8,712,179 shares
Largest sells
Since Q2 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alexion Pharmaceuticals Inc~$1.26BCut · 1.0% → 0.6%−10,284,191 shares
- Monsanto Co~$1.07BCut · 0.5% → 0.1%−10,469,265 shares
- Kinder Morgan~$747.1MCut · 0.5% → 0.4%−32,298,860 shares
- Amgen Inc~$661.2MCut · 4.3% → 4.4%−3,963,776 shares
- Waste Management Inc~$637.2MSold out · 0.2% → 0.0%−9,614,707 shares
- Johnson Controls Inc~$631.3MSold out · 0.2% → 0.0%−14,263,726 shares
- Conocophillips~$588.5MCut · 0.6% → 0.3%−13,538,079 shares
- Texas Instruments~$545.8MCut · 1.8% → 1.8%−7,776,858 shares
- General Dynamics Corp~$515.1MCut · 0.9% → 0.8%−3,319,703 shares
- Baidu~$502.8MCut · 0.4% → 0.2%−2,761,624 shares
Holdings
As of Sep 30, 2016. Changes are in shares against Jun 30, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen IncCOMMON STOCK · shares −4.8% · price +9.6% | 4.4% | $13.16B | +$1.16B | ||||||||
| Abbvie IncCOMMON STOCK · shares +5.6% · price +2.0% | 3.4% | $10.17B | +$187.4M | ||||||||
| AmazonCOMMON STOCK · shares −1.8% · price +17.0% | 3.0% | $8.97B | +$1.30B | ||||||||
| Philip Morris InternationalCOMMON STOCK · shares −1.4% · price −4.4% | 2.6% | $7.96B | −$368.2M | ||||||||
| Verizon Communications IncCOMMON STOCK · shares −3.4% · price −6.9% | 2.6% | $7.82B | −$580.4M | ||||||||
| OracleCOMMON STOCK · shares −1.3% · price −4.0% | 2.1% | $6.32B | −$265.5M | ||||||||
| Texas InstrumentsCOMMON STOCK · shares −9.3% · price +12.0% | 1.8% | $5.30B | +$568.5M | ||||||||
| NetflixCOMMON STOCK · shares +3.6% · price +7.7% | 1.7% | $5.10B | +$353.3M | ||||||||
| Broadcom LtdCOMMON STOCK · shares −0.7% · price +11.0% | 1.6% | $4.86B | +$482.2M | ||||||||
| Union Pacific CorpCOMMON STOCK · shares −7.3% · price +11.8% | 1.6% | $4.82B | +$508.3M | ||||||||
| Altria Group IncCOMMON STOCK · shares −5.0% · price −8.3% | 1.5% | $4.54B | −$411.7M | ||||||||
| Canadian Natural Resources LtdCOMMON STOCK · shares +0.3% · price +3.6% | 1.4% | $4.21B | +$147.2M | ||||||||
| Eog Resources IncCOMMON STOCK · shares +0.05% · price +15.9% | 1.4% | $4.18B | +$573.5M | ||||||||
| American International Group IncCOMMON STOCK · shares +0.4% · price +12.2% | 1.4% | $4.15B | +$449.6M | ||||||||
| AlibabaCOMMON STOCK · shares +7.3% · price +33.0% | 1.4% | $4.10B | +$948.6M | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares −0.00% · price −0.8% | 1.3% | $4.08B | −$34.9M | ||||||||
| IntelCOMMON STOCK · shares +4.4% · price +15.1% | 1.3% | $4.06B | +$510.4M | ||||||||
| Stryker CorpCOMMON STOCK · shares +1.7% · price −2.9% | 1.3% | $3.90B | −$112.8M | ||||||||
| Accenture Plc Cl ACOMMON STOCK · shares −0.4% · price +7.8% | 1.1% | $3.47B | +$252.1M | ||||||||
| AlphabetCOMMON STOCK · shares +4.2% · price +12.3% | 1.1% | $3.43B | +$361.2M | ||||||||
| Coca-Cola CoCOMMON STOCK · shares −0.00% · price −6.6% | 1.1% | $3.35B | −$238.0M | ||||||||
| Medtronic PlcCOMMON STOCK · shares +1.2% · price −0.4% | 1.1% | $3.28B | −$13.9M | ||||||||
| AT&TCOMMON STOCK · shares −6.9% · price −6.0% | 1.0% | $3.15B | −$201.4M | ||||||||
| Boeing CoCOMMON STOCK · shares +4.3% · price +1.4% | 0.90% | $2.71B | +$36.9M | ||||||||
| AlphabetCOMMON STOCK · shares +7.7% · price +14.3% | 0.90% | $2.71B | +$314.5M | ||||||||
| Total · 413 positions | 100% | $302.53B | +$11.83B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2016 to Q3 2016: 386 stocks held throughout, up $11.83B (+4.3%).
- Amazon+$1.30B+17%
- Amgen Inc+$1.16B+10%
- Alibaba+$948.6M+33%
- Eog Resources Inc+$573.5M+16%
- Texas Instruments+$568.5M+12%
- Oracle−$265.5M−4%
- Philip Morris International−$368.2M−4%
- Altria Group Inc−$411.7M−8%
- Kroger Co−$461.4M−19%
- Verizon Communications Inc−$580.4M−7%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |